Press "Enter" to skip to content

‘We Have a Last-Mile Problem’: What We Heard This Week

“We have a last-mile problem now.” — Lisa Fitzpatrick, MD, MPH, MPA, founder and CEO of Grapevine Health, discussing COVID-19 vaccine hesitancy.

“People who don’t have a sore arm shouldn’t assume they’re not protected, and those who do have a sore arm shouldn’t assume they’re more protected than others.” — Robert Schooley, MD, of the University of California San Diego, on varying side effects of the COVID-19 vaccine.

“We owe it to all those who have been impacted — especially patients and their loved ones — to see to it that these materials are placed in the public domain.” — Caleb Alexander, MD, of Johns Hopkins University, on an effort to increase public access to information about the opioid crisis.

“This is the first time that there are good data to show this.” — Paul Harrison, FRCPsych, of University of Oxford in England, discussing research showing one-third of COVID-19 survivors received a neurologic or psychiatric diagnosis within 6 months of being infected.

“The jury is out, in terms of what’s the overall impact [of the pandemic] on preterm birth.” — Rahul Gupta, MD, MPH, chief medical and health officer at March of Dimes, on what happened to preterm birth rates since the arrival of COVID-19.

“There could be thousands of cases of Guillain-Barré syndrome that will occur only by coincidence.” — Anthony Amato, MD, of Harvard Medical School in Boston, about a clinical trial participant who developed Guillain-Barré syndrome after receiving a COVID-19 vaccine.

Source: MedicalNewsToday.com